Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target-Reference-Cited by-同舟云学术

Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target

Published:2017-01-17 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Sizdahkhani Saman,Feldman Michael J.,Piazza Martin G.,Ksendzovsky Alexander,Edwards Nancy A.,Ray-Chaudhury Abhik,Maric Dragan,Merrill Marsha J.,Pacak Karel,Zhuang Zhengping,Chittiboina Prashant

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep40822.pdf

Reference49 articles.

1. Maddock, I. R. et al. A genetic register for von Hippel-Lindau disease. J. Med. Genet. 33, 120–127 (1996).

2. Latif, F. et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993).

3. Chittiboina, P. & Lonser, R. R. Von Hippel-Lindau disease. Handb. Clin. Neurol. 132, 139–56 (2015).

4. Lonser, R. R. et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J. Neurosurg. 120, 1055–62 (2014).

5. Wind, J. J. & Lonser, R. R. Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev. Neurother. 11, 1433–41 (2011).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Somatostatin receptor 2A expression in von Hippel‐Lindau–related hemangioblastomas;Cancer;2024-06-02

2. New Prospects on Neuroimaging in Von Hippel Lindau Disease—A Narrative Review;Diagnostics;2024-01-31

3. Expression of somatostatin receptors in hemangioblastomas associated with von Hippel-Lindau disease as a novel diagnostic, therapeutic, and follow-up opportunity: A case report and literature review;Archives of Endocrinology and Metabolism;2024

4. Emerging therapies of hemangioblastomas;Exploration of Neuroscience;2023-12-29

5. 68Ga-DOTANOC PET/CT for Screening and Surveillance of Von Hippel-Lindau (VHL) disease;Nuclear Medicine and Molecular Imaging;2023-07-05